Potpourri
Department of Health and Hospitals Board of Pharmacy
Compounding for Prescriber’s Use
The Board of Pharmacy (“Board”) published a Notice of Intent to promulgate amendments to LAC 46:LIII.Chapter 25 in the January 20, 2013 edition of the Louisiana Register (LR 39:187-189). The notice solicited comments and testimony. As a result of its analysis of the comments and testimony received, the Board proposes to amend the original proposal by replacing the original language that would have repealed the authority of a pharmacy to compound any drug products for practitioner administration with language that will limit the authority of the pharmacy to compound drug products for practitioner administration up to ten percent of the total number of drug dosage units dispensed and distributed by the pharmacy on an annual basis.
Interested persons may submit written comments to Malcolm J Broussard, Executive Director, Louisiana Board of Pharmacy, 3388 Brentwood Drive, Baton Rouge, Louisiana 70809- 1700. He is responsible for responding to inquiries regarding these substantive amendments to the original proposal. A public hearing on these proposed amendments is scheduled for Thursday, May 30, 2013 at 1:00 p.m. in the Board office. At that time, all interested persons will be afforded an opportunity to submit data, views, or arguments, either orally or in writing. The deadline for the receipt of all comments is 4:00 p.m. that same day.
Malcolm J Broussard Executive Director
Louisiana Board of Pharmacy
Louisiana Board of Pharmacy
There is a lot more information in a pdf regarding the old rule changes to the new rules and the effect on cost. To view this pdf click here
No comments:
Post a Comment